These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 38169754)

  • 1. Exploring the Neuroprotective Effects of Lithium in Ischemic Stroke: A literature review.
    Wang W; Lu D; Shi Y; Wang Y
    Int J Med Sci; 2024; 21(2):284-298. PubMed ID: 38169754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is lithium neuroprotective? An updated mechanistic illustrated review.
    Ghanaatfar F; Ghanaatfar A; Isapour P; Farokhi N; Bozorgniahosseini S; Javadi M; Gholami M; Ulloa L; Coleman-Fuller N; Motaghinejad M
    Fundam Clin Pharmacol; 2023 Feb; 37(1):4-30. PubMed ID: 35996185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.
    Chuang DM; Wang Z; Chiu CT
    Front Mol Neurosci; 2011; 4():15. PubMed ID: 21886605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of PI3K/Akt at Thr308, but not phosphorylation of MAPK kinase, mediates lithium-induced neuroprotection against cerebral ischemia in mice.
    Ates N; Caglayan A; Balcikanli Z; Sertel E; Beker MC; Dilsiz P; Caglayan AB; Celik S; Dasdelen MF; Caglayan B; Yigitbasi T; Ozbek H; Doeppner TR; Hermann DM; Kilic E
    Exp Neurol; 2022 May; 351():113996. PubMed ID: 35122865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae.
    Gold AB; Herrmann N; Lanctôt KL
    Curr Drug Targets; 2011 Feb; 12(2):243-55. PubMed ID: 20863277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium neuroprotection: molecular mechanisms and clinical implications.
    Rowe MK; Chuang DM
    Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new avenue for lithium: intervention in traumatic brain injury.
    Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM
    ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.
    Chiu CT; Chuang DM
    Pharmacol Ther; 2010 Nov; 128(2):281-304. PubMed ID: 20705090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy.
    Damri O; Shemesh N; Agam G
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3 in neurodegeneration and neuroprotection: lessons from lithium.
    Aghdam SY; Barger SW
    Curr Alzheimer Res; 2007 Feb; 4(1):21-31. PubMed ID: 17316163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.
    Guttuso T
    Med Hypotheses; 2019 Oct; 131():109302. PubMed ID: 31443765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective action of lithium in disorders of the central nervous system.
    Chiu CT; Chuang DM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):461-76. PubMed ID: 21743136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
    Gould TD; Manji HK
    Neuropsychopharmacology; 2005 Jul; 30(7):1223-37. PubMed ID: 15827567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke.
    Shen Z; Xiang M; Chen C; Ding F; Wang Y; Shang C; Xin L; Zhang Y; Cui X
    Biomed Pharmacother; 2022 Jul; 151():113125. PubMed ID: 35609367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective Strategies for Ischemic Stroke-Future Perspectives.
    Haupt M; Gerner ST; Bähr M; Doeppner TR
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Strategies for Stroke by Natural Products: Advances and Perspectives.
    Liu A; Hu J; Yeh TS; Wang C; Tang J; Huang X; Chen B; Huangfu L; Yu W; Zhang L
    Curr Neuropharmacol; 2023; 21(11):2283-2309. PubMed ID: 37458258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview of the Neurotrophic and Neuroprotective Properties of the Psychoactive Drug Lithium as an Autophagy Modulator in Neurodegenerative Conditions.
    Singh A; Arora S; Chavan M; Shahbaz S; Jabeen H
    Cureus; 2023 Aug; 15(8):e44051. PubMed ID: 37746513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroprotective effect of lithium chloride on cognitive impairment through glycogen synthase kinase-3β inhibition in intracerebral hemorrhage rats.
    Liu Z; Li R; Jiang C; Zhao S; Li W; Tang X
    Eur J Pharmacol; 2018 Dec; 840():50-59. PubMed ID: 30336136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
    Ikonomov OC; Manji HK
    Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models.
    Kerr F; Bjedov I; Sofola-Adesakin O
    Front Mol Neurosci; 2018; 11():297. PubMed ID: 30210290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.